Scientists believe ibogaine can help veterans overcome PTSD

3 days ago

Ibogaine is a banned hallucinogenic drug derived from the African iboga shrub, traditionally used in spiritual ceremonies, and is being tested for PTSD and addiction treatment.
Trials on US veterans in Mexico showed improvements in PTSD, depression, and anxiety after ibogaine treatment, with benefits linked to intense psychedelic experiences.
Scientists are unsure how ibogaine works; it may involve kappa-opioid receptors, myelination, increased serotonin activity, or neuroplasticity, but its hallucinogenic effects might not be necessary.
Ibogaine has shown promise in reducing opioid withdrawal symptoms and cravings since the 1960s, with some patients reporting insights into addiction causes during trips.
Safety concerns include cardiac risks and fatalities, requiring medical monitoring and magnesium infusions, and treatment is often combined with other psychedelics like 5-MeO-DMT.
Research faces limitations due to observational data, lack of large-scale trials, and high costs, but funding is increasing, including US federal support for ibogaine studies.
Ibogaine is not a miracle cure; some patients don't respond, and post-treatment efforts like journaling and meditation are needed for lasting benefits.

Hasty Briefsbeta